Oprea, A. L. Et Al. 2023. Conventional Tools for Predicting Satisfactory Response to Neoadjuvant Chemotherapy in HR+/HER2-Breast Cancer Patients. BREAST CARE , vol.18 , 344-353.

Oprea, A. L., GÜLLÜOĞLU, M. B., Aytin, Y. E., EREN, Ö. C., Aral, C., Szekely, T., ... Tastekin, E.(2023). Conventional Tools for Predicting Satisfactory Response to Neoadjuvant Chemotherapy in HR+/HER2-Breast Cancer Patients. BREAST CARE , vol.18, 344-353.

Oprea, Adela Et Al. "Conventional Tools for Predicting Satisfactory Response to Neoadjuvant Chemotherapy in HR+/HER2-Breast Cancer Patients," BREAST CARE , vol.18, 344-353, 2023

Oprea, Adela L. Et Al. "Conventional Tools for Predicting Satisfactory Response to Neoadjuvant Chemotherapy in HR+/HER2-Breast Cancer Patients." BREAST CARE , vol.18, pp.344-353, 2023

Oprea, A. L. Et Al. (2023) . "Conventional Tools for Predicting Satisfactory Response to Neoadjuvant Chemotherapy in HR+/HER2-Breast Cancer Patients." BREAST CARE , vol.18, pp.344-353.

@article{article, author={Adela Luciana Oprea Et Al. }, title={Conventional Tools for Predicting Satisfactory Response to Neoadjuvant Chemotherapy in HR+/HER2-Breast Cancer Patients}, journal={BREAST CARE}, year=2023, pages={344-353} }